The general meeting is, as clearly stated, for the purpose of of approving "a placement of 44,444,445 new, fully paid ordinary shares (New Shares) at an offer price of $0.18 per New Share (Offer Price) to raise total proceeds of $8m" and the small additional "638,886 New Shares will be issued to the Directors at the Offer Price" for the net proceeds, before costs of $8.1 million of working capital for the company. The beauty of math, vs your oft declared "facts", is at 99% of the funding, I think we can safely say "eeehhhhh! I'm sorry, your time's run out....typewriter maintenance at the Rocco Globbo School for Women!" it is for you JB.
For a bloke who writes essays, like realllllly long essays, on here, you sure do struggle with reading.
Meanwhile for everyone else, a bit of a result. CYP +4.65% on the day after a raise that puts $8 mill in the coffers. I'd have taken that before this combined announcement, personally.
And for our MSB Trolls (I own MSB, not everyone who does hates CYP and vice versa) who cannot do simple mathematics, do look at recent cash outflows, the R&D rebate of $1.88M and existing likely cash balances at this point and understand they are now funded well into calendar year 2026, not only well beyond the likely completion of the GVHD trial, but beyond the guided results date therein. Off to the Rocco Globbo school for some teaching for you too, Plodge.
My only concern on CYP, taking pity on you and your new best mates well displayed traits, is that it embarks on a new trial in curing both dyslexia and dyscalculia for you both that would admittedly raise those cash outflows.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)